Raymond James Financial Services Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-4,773
| Closed | -$578K | – | 3388 |
|
|
2023
Q1 | $578K | Sell |
4,773
-17
| -0.4% | -$2.06K | ﹤0.01% | 2241 |
|
|
2022
Q4 | $550K | Buy |
4,790
+44
| +0.9% | +$5.05K | ﹤0.01% | 2211 |
|
|
2022
Q3 | $480K | Hold |
4,746
| – | – | ﹤0.01% | 2271 |
|
|
2022
Q2 | $481K | Buy |
4,746
+166
| +4% | +$16.8K | ﹤0.01% | 2298 |
|
|
2022
Q1 | $533K | Buy |
4,580
+338
| +8% | +$39.3K | ﹤0.01% | 2344 |
|
|
2021
Q4 | $486K | Buy |
+4,242
| New | +$486K | ﹤0.01% | 2381 |
|